The global IVD
quality control market is
expected to reach over USD 1.13 billion by 2024 according to a new report by
Grand View Research, Inc.
The continually evolving technology-oriented changes in
the diagnostics field and the growing requirement to ensure patient safety
necessitate the implementation of quality assurance programs in various medical
disciplines including radiology and point-of-care devices.
The patients rely on self-testing IVD devices for
long-term disease management and hence it is important for such IVD devices to
be checked for quality in terms of result reproducibility and validity in order
to guarantee patient safety. The rising number of certified clinical
laboratories offering dependable IVD-based diagnostic services directly
correlates with increased patient confidence, thus driving the quality control
market.
In addition to quality assessments, amendments to the
regulatory framework are made intermittently to enhance the present quality
standards with the main objective of safeguarding qualitative superiority of
the diagnostic services rendered to patients.
In May 2016, the European Union passed an agreement to
update the pre-existing regulations pertaining to IVD devices wherein the
updates were in concern with raising the patient safety levels, particularly
for disabled persons. Furthermore, the presence of third party quality control
agencies for independent assessment of the IVD devices is expected to elevate
the current safety standards, which is expected to further propel the market
growth.
Browse full report by
Grand View Research :
Further key findings from the study suggest:
·
In 2015, the clinical chemistry segment
dominated the IVD quality control market with a share of over 35%. The
increasing demand for preventive medicine and the rapid transformation of
clinical laboratories into highly automated and efficient businesses are some
of the factors for its large market share.
·
The molecular diagnostics is one of the
fastest growing segments during the forecast period owing to the increasing
technical complexity of molecular diagnostic testing coupled with the constant
need for quality evaluation to ensure standards. The molecular diagnostics
tests are of prime importance as the test outcomes enable healthcare
practitioners make critical treatment decisions.
·
The hospital segment held the largest share
in 2015 due to the presence of highly advanced technology-based devices, such
as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays,
and the rising applications of the optimized quality-control procedures
·
The North America contributed over 43% of
the market share in 2015 attributable to the presence of over 150,000
registered diagnostics laboratories. The clinical laboratories are required to
provide accurate results and maintain the accuracy standards in order to retain
their license to operate.
·
Many pharmaceutical companies are
implementing the new draft guidance enforced by the U.S. FDA for data integrity
on current Good Manufacturing Practices (cGMP).It provides information in
relation to establishing robust operating procedures and strong quality
management systems, obtaining high-quality raw materials, investigating quality
deviations, and maintaining reliable diagnostic laboratories
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the IVD quality control market on the basis of application, type,
end-use, and region:
IVD Quality
Control Market Application Outlook, by Revenue (USD Million, 2013 - 2024)
·
Clinical Chemistry
·
Immunochemistry
·
Hematology
·
Molecular Diagnostics
·
Coagulation
·
Microbiology
·
Others
IVD Quality
Control Market Type Outlook, by Revenue (USD Million), 2013 - 2024
·
Quality Controls
o
Plasma-based Controls
o
Serum-based Controls
o
Whole Blood-based Controls
o
Other IVD Quality Controls
·
Data Management
·
Quality Assurance Services
IVD Quality
Control Market End-use Outlook, by Revenue (USD Million), 2013 - 2024
·
Home-care
·
Laboratory
·
Hospitals
·
Others
IVD Quality
Control Market Regional Outlook, by Revenue (USD Million), 2013 - 2024
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
MEA
o
South Africa
Access
press release by Grand View Research:
control-marketAbout
Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
more information: http://www.grandviewresearch.com
